Association between the dietary inflammatory index and risk of lung cancer: a multi-centered case-control study
- PMID: 39593000
- PMCID: PMC11590501
- DOI: 10.1186/s12885-024-13189-3
Association between the dietary inflammatory index and risk of lung cancer: a multi-centered case-control study
Abstract
Purpose: Dietary factors might contribute to the risk of lung cancer by increasing the concentration of inflammatory markers. The literature-derived Dietary Inflammatory Index (DII) has been established to evaluate the inflammatory potential of diet correlated with inflammatory markers. The association between DII scores and the risk of lung cancer has been conflicting. So, in the current study, we aimed to assess the effect of pro-inflammatory dietary patterns measured with DII and the risk of lung cancer.
Methods: A multi-center case-control study was carried out on 616 patients with lung cancer and 3412 healthy controls. Dietary intakes were collected using a 131-item food frequency questionnaire during a face-to-face interview. The DII scores including thirty-six nutrients were calculated after energy adjustments. Finally, the association between DII level and the risk of lung cancer was evaluated by performing a multi-variable regression method after adjusting for potential confounders.
Results: The risk of overall lung cancer, small cell, and squamous cell carcinoma was elevated in the third tertile compared to the first tertile of the DII score, (odds ratio [OR] T3 vs. T1 of overall lung cancer = 1.38 (95% confidence interval [CI] 1.08-1.77), P trend = 0.01, OR T3 vs. T1 of squamous cell lung cancer = 1.82 (95% CI 1.02-3.24), P trend = 0.04, OR T3 vs. T1 of small cell lung cancer = 1.66 (95% CI 1.08-2.54), P trend = 0.019). However, no increase was observed in the risk of adenocarcinoma by adherence to a pro-inflammatory dietary pattern.
Conclusion: A positive link was found between DII and the risk of overall lung cancer, small-cell, and squamous-cell lung cancer. However, there was no association between DII and the risk of lung adenocarcinoma.
Keywords: Case-control; Diet; Iran; Lung cancer.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Informed consent was obtained from all participants in the study. The study protocol of the whole project was approved by the National Institute of Medical Research Development (NIMAD), (Grant number: 940045). Before entering the study, objectives were explained to all participants individually. The ethics committee of Tehran University of Medical Sciences has approved this study (no. IR. TUMS.IKHC.REC.1400.314.). Consent for publication: We do not publish any data on the names of the participants. Competing interests: The authors declare no competing interests.
Figures
References
-
- 2022 GGLOBOCAN. 2022: Latest global cancer data shows rising incidence and stark inequities. UICC2024.
-
- Malvezzi M, Carioli G, Bertuccio P, Rosso T, Boffetta P, Levi F, et al. European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol. 2016;27(4):725–31. - PubMed
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. - PubMed
-
- Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, et al. Cancer incidence in five continents: inclusion criteria, highlights from X and the global status of cancer registration. Int J Cancer. 2015;137(9):2060–71. - PubMed
-
- Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3):889–902. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
